Connect with us

Health

Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia – Wiley

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The…

Published

on

Article feature image

Adults and children with acute leukaemia are at high risk of serious illness and death from COVID-19, compared with the general population.1, 2 Furthermore, delayed or interrupted leukaemia treatment due to SARS-CoV-2 infection may also result in poor prognosis,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending